Krilogy Financial LLC Crispr Therapeutics Ag Transaction History

Krilogy Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$51.17 - $68.18 $514,258 - $685,209	10,050 Added 92.87%	20,872 $1.13 Million
Q1 2024 Apr 24, 2024	SELL	$60.67 - $89.12 $295,584 - $434,192	-4,872 Reduced 31.04%	10,822 $737,000
Q4 2023 Jan 26, 2024	BUY	$38.62 - $72.18 $606,102 - $1.13 Million	15,694 New	15,694 $982,000
Q2 2018 Aug 15, 2018	SELL	$42.62 - $73.59 $8,524 - $14,718	-200 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$23.52 - $58.17 $2,352 - $5,817	-100 Reduced 33.33%	200 $9,000
Q2 2017 Aug 15, 2017	BUY	N/A	300	300 $5,000

510

57.4M

1.74M

1.84M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.96B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.